Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elidel in children with mild to moderate facial atopic dermatitis
2005-001650-25Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pimecrolimus in atopic dermatitis (AD) (3 arms), sponsored by Novartis. Started May 2005; status: completed.
02
Drugs
pimecrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2005-001650-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001650-25.